Hinge Health Q2 Revenue Surges 53%, Beats by $11.8M; Raises Full-Year Guidance
HNGE has more than doubled off its 52-week low of $30.08.
Summary
Hinge Health delivered a standout Q2 with revenue of $212.82M, up 53% year-over-year and well above the $201M consensus. The company reported Q2 EPS of 52c and adjusted EPS of 59c. Management raised full-year 2026 revenue guidance to $856M-$860M, implying continued momentum, and guided for a 28% non-GAAP operating margin. The company also announced the acquisition of Cylinder Health, expanding into gastrointestinal care, and intends to launch an integrated GI care program. For Q3, Hinge Health sees revenue of $223M-$225M. The beat was driven by strong member conversion, rapid adoption of its Migraine Care Program, and 24% client growth to 2,929.
At the time of this announcement, HNGE was trading at $76.49 on NYSE in the Technology sector, with a market capitalization of approximately $6.1B. The 52-week trading range was $30.08 to $91.50. This news item was assessed with positive market sentiment and an importance score of 9 out of 10. Source: Reuters.